In a range of tumor types, including NSCLC, ovarian cancer, oral cancer, gastric cancer and melanoma, HDGF is overexpressed, and its higher expression is strongly correlated with poor prognosis [6–11]. This evidence concerns the gene HDGF and non-small cell lung carcinoma.